These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15467035)

  • 21. Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.
    Thompson J; Zamboni WC; Cheshire PJ; Lutz L; Luo X; Li Y; Houghton JA; Stewart CF; Houghton PJ
    Clin Cancer Res; 1997 Mar; 3(3):423-31. PubMed ID: 9815701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of chemotherapeutic drug resistance in neuroblastoma SK-N-AS cells by the neural apoptosis inhibitory protein and miR-520f.
    Harvey H; Piskareva O; Creevey L; Alcock LC; Buckley PG; O'Sullivan MJ; Segura MF; Gallego S; Stallings RL; Bray IM
    Int J Cancer; 2015 Apr; 136(7):1579-88. PubMed ID: 25137037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
    Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-141 and its associated gene FUS modulate proliferation, migration and cisplatin chemosensitivity in neuroblastoma cell lines.
    Wang Z; Lei H; Sun Q
    Oncol Rep; 2016 May; 35(5):2943-51. PubMed ID: 26936280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
    Voigt A; Zintl F
    Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts.
    Zamboni WC; Houghton PJ; Thompson J; Cheshire PJ; Hanna SK; Richmond LB; Lou X; Stewart CF
    Clin Cancer Res; 1998 Feb; 4(2):455-62. PubMed ID: 9516936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.
    Veneziani I; Brandetti E; Ognibene M; Pezzolo A; Pistoia V; Cifaldi L
    J Immunol Res; 2018; 2018():4972410. PubMed ID: 29805983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allosteric and Orthosteric Activators of mGluR8 Differentially Affect the Chemotherapeutic-Induced Human Neuroblastoma SH-SY5Y Cell Damage: The Impact of Cell Differentiation State.
    Jantas D; Grygier B; Zatorska J; Lasoń W
    Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):443-451. PubMed ID: 29753314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of class I and II vs class III histone deacetylase inhibitors in neuroblastoma.
    Lautz TB; Naiditch JA; Clark S; Chu F; Madonna MB
    J Pediatr Surg; 2012 Jun; 47(6):1267-71. PubMed ID: 22703804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo.
    Wickström M; Johnsen JI; Ponthan F; Segerström L; Sveinbjörnsson B; Lindskog M; Lövborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
    Mol Cancer Ther; 2007 Sep; 6(9):2409-17. PubMed ID: 17876040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodal assessment of early tumor response to chemotherapy: comparison between diffusion-weighted MRI, 1H-MR spectroscopy of choline and USPIO particles targeted at cell death.
    Radermacher KA; Magat J; Bouzin C; Laurent S; Dresselaers T; Himmelreich U; Boutry S; Mahieu I; Vander Elst L; Feron O; Muller RN; Jordan BF; Gallez B
    NMR Biomed; 2012 Apr; 25(4):514-22. PubMed ID: 21874657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to chemotherapy mediated by TrkB in neuroblastomas.
    Ho R; Eggert A; Hishiki T; Minturn JE; Ikegaki N; Foster P; Camoratto AM; Evans AE; Brodeur GM
    Cancer Res; 2002 Nov; 62(22):6462-6. PubMed ID: 12438236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of chemotherapy resistance genes in outcome of neuroblastoma.
    de Cremoux P; Jourdan-Da-Silva N; Couturier J; Tran-Perennou C; Schleiermacher G; Fehlbaum P; Doz F; Mosseri V; Delattre O; Klijanienko J; Vielh P; Michon J
    Pediatr Blood Cancer; 2007 Mar; 48(3):311-7. PubMed ID: 16609945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
    Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
    Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of DNA methyltransferase reverses cisplatin induced drug resistance in murine neuroblastoma cells.
    Qiu YY; Mirkin BL; Dwivedi RS
    Cancer Detect Prev; 2005; 29(5):456-63. PubMed ID: 16185816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide inhibits cell growth in SH-SY5Y and SK-N-AS neuroblastoma cell lines by a different mechanism.
    Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Shin HY; Ahn HS; Ryu KH
    Pediatr Hematol Oncol; 2006; 23(3):231-43. PubMed ID: 16517539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-vivo metabolic characterization of healthy prostate and orthotopic prostate cancer in rats using proton magnetic resonance spectroscopy at 4.7 T.
    Walker P; Provent P; Tizon X; Créhange G; Duchamp O; Brunotte F; Genne P
    Acta Radiol; 2013 Feb; 54(1):121-6. PubMed ID: 23081956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
    Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
    Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
    Ora I; Bondesson L; Jönsson C; Ljungberg J; Pörn-Ares I; Garwicz S; Pâhlman S
    Biochem Biophys Res Commun; 2000 Oct; 277(1):179-85. PubMed ID: 11027660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting methylguanine-DNA methyltransferase in the treatment of neuroblastoma.
    Wagner LM; McLendon RE; Yoon KJ; Weiss BD; Billups CA; Danks MK
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5418-25. PubMed ID: 17875772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.